Atelerix Life Sciences is a biotechnology company developing cutting-edge proprietary small molecules for the process of addiction.
Atelerix Life Sciences has raised $650K in total funding. The most recent round was Seed. The last funding was announced in October 2022.
Atelerix Life Sciences is headquartered in Charlottesville, United States.
Atelerix Life Sciences is a biotechnology company developing cutting-edge proprietary small molecules for the process of addiction.
Atelerix Life Sciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atelerix Life Sciences — Funding & Investors." VCBacked, October 1, 2022, https://www.vcbacked.co/company/atelerix-life-sciences. Accessed September 30, 2026.
VCBacked. (2022). Atelerix Life Sciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/atelerix-life-sciences
{{cite web |title=Atelerix Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/atelerix-life-sciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated